METTL3 and non-small cell lung carcinoma: As demonstrated in the extant literature, METTL3 in CAFs-derived exosomes has been shown to promote proliferation, invasion, and glutamine metabolism in non-small cell lung cancer (NSCLC) cells by inducing m6A modification of SLC7A5 and stabilising its expression [133].